You are here

  • Home
  • Archive
  • Volume 8, Issue 10
  • The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial

Citation Tools

Article menu

Download PDFPDF

XML
Ophthalmology
Protocol
The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Balal S, Udoh A, Pappas Y, et al
The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial
BMJ Open 2018;8:e026770. doi: 10.1136/bmjopen-2018-026770